Cannabis Science Global Health Summit Presentations

Cannabis Science Global Health Summit Presentations

The GHC summit at Harvard, is a yearly event designed to catalyze collaborations to eliminate...

 
  • GHC 2018

    May 2018, the Cannabis Science team participated in the 2018 Global Health Catalyst Summit held at Harvard Medical School in Boston, MA. The Global Health Catalyst (GHC) summit at Harvard, is a premier yearly event designed to catalyze high impact international collaborations to eliminate global health disparities, with main focus on cancer and related diseases. During this summit Mr. Raymond C. Dabney, the Company’s President, Chief Executive Officer (CEO), and Co-founder was named the recipient of the esteemed 2018 Harvard Global Health Catalyst (GHC) Industry Leader Award and was the keynote speaker during the Phytomedicines Session.


    The theme of the Phytomedicines Session was From Farm to Bedside: Advancing Clinical Translation of Medical Cannabis and Other Phytomedicines for Global Health. Mr. Dabney discussed the development of effective cannabinoids and the creation of the Cannabis Science Global Consortium, a research and development framework and platform to cooperate and collaborate with stakeholders worldwide. 

    Cannabis Science’s Chief Medical Officer (CMO), Dr. Allen Herman, moderated the Phytomedicines Session and also presented on the role of cannabinoids in reducing the pain therapeutic divide between developed and developing countries, and CBIS’ research and development plan.

    Pan African Ambassador for Food Security and member of the Cannabis Science Scientific Advisory Board, Dr. Brylyne Chitsunge, discussed opportunities to cultivate, extract, manufacture, package, and distribute cannabinoids in Sub-Saharan Africa along with the task of educating the rest of the continent through actions and success. The Ambassador’s main take away for the audience was the emphasis of the importance of micro-nutrition and food security within the overall approach to improve healthcare outcomes throughout all of Africa.


    GHC Europe 2018

    Cannabis Science participated in the Europe Global Health Catalyst (GHC) Summit and Summer Workshop in Germany, organized by at the University of Heidelberg and Harvard Medical School’s Global Health Catalyst. CBIS’ Scientific Advisory Board Member and Chief Executive Officer (CEO) of Elpasso Farms in South Africa, Dr. Brylyne Chitsunge, was invited to deliver a keynote address on engaging the African Diaspora, phytomedicines in global health, and closing the cancer pain divide. This two-day event held August 30th and 31st, is a pre-summit to the annual GHC Summit at Harvard Medical School in Boston, Massachusetts, and was attended by government officials, private-sector leaders, and researchers from Europe, the United States, and throughout Africa.

    As keynote speaker, Dr. Chitsunge also discussed Elpasso Farms’ and Cannabis Science’s initiatives in Africa in the areas of food security, collaborations, and economic development. The economic development initiatives presented include education, drug development, and job creation.

    Cannabis Science and Elpasso Farms have recently entered into an agreement to develop a phytomedicines initiative in South Africa. This partnership will include establishing research, development, cultivation, testing, manufacturing, and production facilities. Additionally, CBIS and Elpasso intend to establish the Pan-African Agriculture and Commerce University (PAACU), which will serve as a platform for research, drug development, education, and training throughout Africa.


    Additionally, Cannabis Science, Elpasso Farms, and Harvard Medical School’s GHC recently announced the signing of a historic collaboration agreement to develop initiatives throughout

    GHC 2017

    April 2017, the Cannabis Science team participated in the 2017 Global Health Catalyst Summit held at Harvard Medical School in Boston, MA. Mr. Dabney was the keynote speaker and panelist for a special session on “Cannabis Science Versus Cancer and Other Malignancies”.


    Mr. Dabney discussed how cannabinoids can be used to treat cancer and other diseases, manage the side effects of cancer treatment like radiotherapy and chemotherapy, and potential applications of medical cannabis in global health to close the global pain divide; Cannabis Science’s vision for the global health and development impact of cannabinoid-based medicines; and the need for greater public education on the importance of medical cannabis research. 

    Additionally, Mr. Dabney presented summit participants with an overview of the company's drug development program, as well as with an update on Cannabis Science's Collaborative Research Agreement (CRA) with Dana-Farber Cancer Institute (Dana-Farber). Dr. Allen Herman, Chief Medical Officer (CMO) of CBIS, Inc. Co-Chaired this session and participated in the discussion on the epidemiology of cancer and the utilization of opioids in Africa, which reflects the pain divide. Mr. Dabney and Dr. Herman lead CBIS’ collaboration with DFCI. 

  • Category
    General
  • Created
    Thursday, 24 January 2019
  • Group admin
    Raymond C. Dabney

American States University

Drug Valuation Image3New_ASU_Logo_Picture1.png


 

Recent GBXI News:

June 22, 2023, GBX International Group, Inc., (OTC: GBXI)
Breaking Cancer Barriers; Investments in Low-Cost, Harvard Award-Winning, Effective Cancer Killing Drugs Now; GBXI Proceeds to Raise $1 Million to Fast-Track its' Success, Cancer Drug Valuations, Access for Patients, Full Company Audit, and Accelerate the Trading of the CSi-Spinout Shares

 

May 11, 2023, GBX International Group, Inc., (OTC: GBXI)
GBX International Group, Inc. (OTC:GBXI) Confirms 2023 Strong Revenue Growth Guidance Projections by Combining Each Acquired Operating Company Product Release, Expects Strong Growth Sector by Sector Through its Multiple Product Releases into North American and International Markets


April 21, 2023, GBX International Group, Inc., (OTC: GBXI)

HARVARD Award Winning Entrepreneur, Mr. Raymond C. Dabney Acquires Majority Shareholder Control of GBX International Group, Inc. (OTC: GBXI) Makes More History Bringing CSi-EDP Partner American States University (ASU) as the First Acquisition for its Aggressive Growth Plans 



Harvard GHC Award RCD 2018

 

The ASU Digital Business HUB will be used as the main business student learning center. GBXI will be the main pivot point to spin out trading shares of all our Partner Public and Private Companies such as Cannabis Science, iCannabinoid, Thermic Science, LNC, LMG, and a few more old and new school surprises for our loyal shareholders. No one will be missed! A true Digital Business HUB for students, just as planned all along.

Each spinout company will give our GBXI registered shareholders additional pro-rata shares in each spinout company over and above their original shares in each entity. This provides the required shareholder base for each company required to trade and gives additional shares to all our loyal GBXI shareholders.

We call this “Compounding our Wealth” through extra spinout share participation for all our loyal GBXI shareholders. Each registered GBXI shareholder will receive additional shares of each spinout Company over and above their original shares to enjoy additional liquidity as each company begins to trade through the GBXI Digital Business HUB spinout process.

 

Click here to review the Report:

Frontiers Capture
1mmStrong July 8 Court UPDATE Brochure Image

Sac Court Capture

Case No. 2:17-CV-02271-KJM-JDP



Inspire, Dream, Change

YOUR DIGITAL ERA Personal & Business Access Learning HUB
 



Observational Studies

PART

Notifications

Activity Stream

Here's one thought Raymond. IF positive things are coming, then a company will some times buy back shares. Are you in a position to do that?

I have been waiting for this CBIS stock to trade to get back on the market. It stop trading 10/25/2019 over 4 years now.

Raymond C. Dabney Thanks for reading our updates Jerry. That is correct we are ALL waiting patiently for the same stock exchange approval process.

Not sure how many...
Show more
2 weeks ago
loader
loader
Attachment
marc rose if this stock will ever come back , now is the time for it to happen....!!!!! 2 weeks ago
loader
loader
Attachment

Cannabis Science Inc. "Shareholder Loyalty Gift Center of Excellence"

HARVARD Award Winning 
CANCER Killing Success





1st HARVARD Award Winning
Stage 4 Lung Cancer Killing Article:
*** Please click image below.

Frontiers_1.JPG


2nd HARVARD Award Winning
Stage 4 Lung Cancer Killing Article:
*** Please click image below.

 Frontiers_2.JPG


*** PLUS

(3) other Cannabis Science
REAL WORLD Successes:

Stage 4 Breast Cancer

WhatsApp_Image_2022-05-21_at_9.37.37_AM_3.jpg
Skin Cancer 

WhatsApp_Image_2022-05-21_at_9.37.38_AM.jpeg
Karposis Sarcoma

WhatsApp_Image_2022-05-21_at_9.37.38_AM_1.jpeg

CSi Final GIFT Share Issuance Nov 27 2022



Cannabis Science CEO, Presents …

The FINAL “CBIS GIFT Shares” Issuances!

DECEMBER 1, 2022, Cheers! & HAPPY HOLIDAYS !!!

ALL GIFT Shares 1, 2, & 3 being ISSUED !!!

 LAST Steps:

Please confirm Yours NOW !!!

1. CONFIRM Correct Total Share Amount(s)

2. CONFIRM Correct Name(s) on CERTIFICATE

3. CONFIRM Correct Mailing Address

ASU/CSi-EDP-ECO-System
At it's FINEST !!! 

WHICH ONE ARE YOU ??

Those who, MAKE things happen.
Those who WATCH things happen.
Those who WONDER what the ... HAPPENED ???

We can make this HAPPEN way FASTER Working as a TEAM !!!

WHAT Matters is how much you CARE about KILLING CANCERS ...

This is it ... We are ALL Here ... Now ... with a Bunch of Celebrities going on TV Worldwide to Start raising $20 Million to Keep Killing Cancers.



2023 Audit considerations NASDAQ.

Cannabis Science Inc.
Share Structure 2023

Par Value: $0.001 USD
Last Price: $0.00647 USD
OTC Markets.

Common Stock:
Authorized:
5,000,000,000
Issued:
2,521,095,296

Class A Common Stock
Authorized:
100,000,000
Issued:
0

Class B Common Stock
Authorized:
1,500,000,000
Issued:
0

Preferred Stock
Authorized:
1,000,000
Issued:
1,000,000



Sign up for a FREE Assessment to JOIN the UNIVERSITY Team or any ASU/CSi-EDP Team for whatever your AREA of Expertise is … then say no more… you already know.

You already know our Extensive LIST of GROUNDBREAKING Products.

1-Million STRONG TV Coverage, HARVARD Award Success.

TAKE YOUR PICK AND BECOME A PART OF HISTORICAL CHANGE




*** APPLY for FREE in CONFIDENCE and Success.

Each Product launch WE RELEASE will include Equity Participation according to standard salaries and share bonus structures.

EVERYONE sign up to add your STRENGTHS to OUR COMBINED SUCCESS and lets MAKE THIS HAPPEN NOW !!!

 

Events

Sorry, we currently have no events.
View All Events